Adrenal Gland Diseases clinical trials
The registry lists 25 studies for Adrenal Gland Diseases across more than 10 countries. 7 are recruiting or about to start. 11 of them are mainly about Adrenal Gland Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 12 narrower conditions too, such as Hyperaldosteronism: 784 studies, 232 open.
Get an email when these change. Save the Adrenal Gland Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Spruce Biosciences (4) · M.D. Anderson Cancer Center (2) · University of Roma La Sapienza (2) · Seoul National University Hospital (2) · University Hospital, Lille (1) · King's College Hospital NHS Trust (1) · Neurocrine Biosciences (1) · University Hospital Olomouc (1)
What is being tested here
Drugs under test in Adrenal Gland Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Tildacerfont | 0 | 0 | 2 |
| Hydrocortisone | 0 | 0 | 1 |
| Relacorilant | 0 | 0 | 1 |
| NBI 77860 | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026Benign and Malignant Adrenal Gland Surgery: Single Center Experience · University of Roma La Sapienza
Who these studies take
Of the 5 Adrenal Gland Diseases studies recruiting now, 3 (60%) set no upper age limit and 1 (20%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (20%) | 1 (20%) |
| 18 | 5 (100%) | 5 (100%) |
| 30 | 5 (100%) | 5 (100%) |
| 40 | 5 (100%) | 5 (100%) |
| 50 | 5 (100%) | 5 (100%) |
| 65 | 5 (100%) | 5 (100%) |
| 75 | 5 (100%) | 5 (100%) |
| 85 | 4 (80%) | 4 (80%) |
Across all 25 studies, recruiting or not: 20% stop at 75 or younger and 12% at 65; 28% take children; 8% are for women only and 0% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Studies
Recruiting first, then most recently updated. Showing 25 of 25. search them.
- Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)RecruitingNCT079201981 country
- Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine DisordersRecruitingNCT078241021 country
- Benign and Malignant Adrenal Gland Surgery: Single Center ExperienceNot yet recruitingNCT075774271 country
- The ARISE Trial Compares Whether Giving Routine Steroid Replacement or Using Targeted Blood Tests to Guide Replacement Better Protects Certain Patients From Adrenal Insufficiency After the Removal of a Diseased Adrenal Gland.Not yet recruitingNCT07558135Not applicable
- Shanghai Clinical Cohort - Adrenal DiseaseRecruitingNCT071919511 country
- Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyRecruitingNCT060500571 country
- Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal DiseaseRecruitingNCT030507621 country
- Prospective Phenotyping of Autonomous Aldosterone SecretionActive, not recruitingNCT034841301 country
- A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAHTerminatedNCT05128942Phase 21 country
- A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal AndrogensTerminatedNCT05370521Phase 21 country
- A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAHTerminatedNCT04544410Phase 216 countries
- A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAHTerminatedNCT04457336Phase 220 countries
- Subcutaneous Hydrocortisone Children With Congenital Adrenal HyperplasiaCompletedNCT03718234Phase 11 country
- Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)CompletedNCT04373265Phase 11 country
- Steroid Panel for One-step Diagnosis of Adrenal DiseasesCompletedNCT049489701 country
- PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic OriginStatus unknownNCT048566831 country
- Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS)Status unknownNCT053222651 country
- DAnalysis of the Distribution of Adrenal Steroids in a Control PopulationCompletedNCT041394471 country
- Unilateral Laparoscopic Adrenalectomy for Resistant Hypertension in Patients With Adrenal DiseasesStatus unknownNCT03535532Not applicable1 country
- EUS-guided FNA in the Study of the Adrenal GlandCompletedNCT03327142
- Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic AdrenalectomyCompletedNCT01676025Not applicable1 country
- Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative StudyCompletedNCT02618694Not applicable1 country
- Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal HyperplasiaWithdrawnNCT02349503Phase 11 country
- Lipid-poor Adrenal Masses: Evaluation With Chemical Shift MRICompletedNCT00721929Not applicable1 country
- Iodine I-131 Iodocholesterol, Its Use in Adrenal ScreeningCompletedNCT00037843Phase 31 country